Study in Pediatrics with HypEREosinophilic syndrome (SPHERE)

Trial Identifier:	215360
Sponsor:	GlaxoSmithKline
Collaborator:	NA
Start Date:	July 2022
Primary Completion Date:	October 2025
Study Completion Date:	October 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
ARGENTINA	Buenos Aires, ARGENTINA, C1028AAP

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.